Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK-guided EHL FVIII Prophylaxis in Thai Hemophilia A
NCT05281185Phase 4Completed
- Sponsor
- Chulalongkorn University
- Start
- Jul 2021
- Primary completion
- Mar 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of recombinant coagulation factor viii in hemophilia A, sponsored by Chulalongkorn University. Started Jul 2021; status: completed.
02
Drugs
recombinant coagulation factor viii
03
Conditions
hemophilia A
Beyond the preview
Go deeper on NCT05281185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05281185.